Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-01-20 @ 3:16 AM
Study NCT ID:
NCT05994157
Status:
RECRUITING
Last Update Posted:
2025-01-29
First Post:
2023-08-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1, Open-label, Dose-escalation Trial with CD38-SADA:177 Lu-DOTA Drug Complex in Subjects with Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor:
Y-mAbs Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-08
First Submit QC Date:
None
Study First Post Date:
2023-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-27
Last Update Post Date:
2025-01-29
Last Update Post Date Type:
ACTUAL